JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
RNA Research Solutions

RNA Research Solutions

B1702 Cholesterol

3 Citation

Summary: A major sterol required for building and maintaining membranes; high-cholesterol diet feeding constructs atherosclerosis models in rabbits.
C1042 SM-102

6 Citation

insoluble in DMSO; ≥175.8 mg/mL
B8595 ALC-0315

Summary: ALC-0315 is an ionizable amino lipid that can be combined with other lipids to form lipid nanoparticles (LNP). LNP containing ALC-0315 can be utilized for the delivery of mRNA vaccines.

≥59.3 mg/mL
B8596 ALC-0159

1 Citation

Summary: ALC-0159 is a lipid excipient. ALC-0159-containing formulation have been used to develop lipid nanoparticles (LNPs) for the delivery of mRNA-based vaccines.

≥39.4 mg/mL
R1021 EZ Cap™ Renilla Luc mRNA

Summary: Renilla Luc mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
R1022 EZ Cap™ Renilla Luc mRNA (5-moUTP)

Summary: Renilla Luc mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
R1023 EZ Cap™ Human p53 mRNA

1 Citation

Summary: Human p53 mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
R1024 EZ Cap™ Human p53 mRNA (ψUTP)

Summary: Human p53 mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
R1025 EZ Cap™ Human PTEN mRNA

2 Citation

Summary: Human PTEN mRNA with Cap 1 structure, providing higher transcription efficiency and enhanced stability.
R1026 EZ Cap™ Human PTEN mRNA (ψUTP)

Summary: Human PTEN mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.